APA (7th ed.) Citation

Takakuwa, T., Yamamura, R., Ohta, K., Kaneko, H., Imada, K., Nakaya, A., . . . Yagi, H. (2021). Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis. European Journal of Haematology, 106(4), 555. https://doi.org/10.1111/ejh.13586

Chicago Style (17th ed.) Citation

Takakuwa, Teruhito, et al. "Outcomes of Ixazomib/lenalidomide/dexamethasone for Multiple Myeloma: A Multicenter Retrospective Analysis." European Journal of Haematology 106, no. 4 (2021): 555. https://doi.org/10.1111/ejh.13586.

MLA (9th ed.) Citation

Takakuwa, Teruhito, et al. "Outcomes of Ixazomib/lenalidomide/dexamethasone for Multiple Myeloma: A Multicenter Retrospective Analysis." European Journal of Haematology, vol. 106, no. 4, 2021, p. 555, https://doi.org/10.1111/ejh.13586.